Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
---|---|
Janssen COVID-19 vaccine: Fact sheet for healthcare providers administering vaccine | Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations |
Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera.
21How CDC is making COVID-19 recommendations | Centers for Disease Control and Prevention |
---|---|
Centers for Disease Control and Prevention | Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States |
Information about COVID-19 vaccines for people with allergies.
5